Nachrichten zur Johnson & Johnson Aktie

Johnson & Johnson verfehlt 2022 eigene Wachstumsziele

NEW BRUNSWICK (dpa-AFX) - Weniger verkaufte Covid-Impfungen und der starke Dollar haben den Pharma- und Konsumgüterkonzern Johnson & Johnson (JohnsonJohnson)…

Johnson & Johnson verfehlt 2022 eigene Wachstumsziele

NEW BRUNSWICK (dpa-AFX) - Weniger verkaufte Covid-Impfungen und der starke Dollar haben den Pharma- und Konsumgüterkonzern…

Wall Street Might Open Lower

NEW BRUNSWICK (dpa-AFX) - Trading on Tuesday may be impacted by reaction to the latest quarterly reports. In the pre-market…

Johnson & Johnson: Die Zahlen zum vierten Quartal fallen rundum solide aus - Aktienanalyse

Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von der Raiffeisen Bank International AG: Benedikt-Luka Antic, Analyst der Raiffeisen Bank International AG (RBI),…

Johnson & Johnson Q4 Profit Down 26%, But Adj. EPS Tops Estimates

NEW BRUNSWICK (dpa-AFX) - Healthcare company Johnson & Johnson (JNJ) on Tuesday reported that profit for fourth quarter declined 25.9…

Form 8-K JOHNSON & JOHNSON For: Jan 24

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Johnson & Johnson Q4 Profit Down 26%, But Adj. EPS Tops Estimates

Healthcare company Johnson & Johnson on Tuesday reported that profit for fourth quarter declined 25.9 percent from last year, reflecting…

Johnson & Johnson Q4 Profit Decreases, but beats estimates

NEW BRUNSWICK (dpa-AFX) - Johnson & Johnson (JNJ) reported earnings for fourth quarter that decreased from the same period last…

J&J tops 4Q earnings forecasts as profit, revenue slip

Johnson & Johnson beat earnings expectations in the final quarter of 2022 even as a strong dollar and sinking COVID-19…

J&J stock rises after 2023 profit view tops analyst outlook

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

J&J forecasts strong 2023 profit on strength in pharma unit

...(Reuters) -Johnson & Johnson on Tuesday forecast annual profit above......…

UPDATE 1-J&J forecasts strong 2023 profit on strength in pharma unit

...(Adds forecast) Jan 24 (Reuters) - Johnson & Johnson on Tuesday......…

J&J quarterly profit beats on pharmaceuticals strength

...Jan 24 (Reuters) - Johnson & Johnson beat estimates for fourth......…

Johnson & Johnson Non-GAAP EPS of $2.35 beats by $0.11, revenue of $23.7B misses by $200M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

GE, Microsoft, JNJ, Lyft, and More Stock Market Movers

General Electric and Johnson & Johnson are scheduled to report earnings before the stock market opens Tuesday. Microsoft will report…

Johnson & Johnson stock outperforms competitors despite losses on the day

Johnson & Johnson stock outperforms competitors despite losses on the day...…

J&J Snack Foods (JJSF) Reports Next Week: Wall Street Expects Earnings Growth

J&J Snack Foods (JJSF) doesnt possess the right combination of the two key ingredients for a likely earnings beat in…

J&J Earnings Could Show Big Pharma Is No Longer a Haven

Drugs giant Johnson & Johnson will report fourth-quarter and full-year earnings early Tuesday. Earlier this month, it had warned the…

Immunyx Pharma Selected to Join BLUE KNIGHT™

NEW YORK and JERUSALEM, Jan. 23, 2023 /PRNewswire/ -- Immunyx Pharma, a developer of immune modulating therapies for neutrophil based…

Wall Street Poised To Open In Negative Territory

BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Earnings will be the focus on Monday and the coming days this week. General Electric, Johnson &…

Wall Street Poised To Open In Negative Territory

Earnings will be the focus on Monday and the coming days this week. General Electric, Johnson & Johnson, Verizon, Microsoft,…

Morphic says Johnson & Johnson unit ended research collaboration

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

HIV-Impfstoff: Nach dem J&J-Flop – hoffen auf BioNTech und Moderna

In Rekordzeit wurden Impfstoffe gegen Corona entwickelt. Doch noch immer gibt es keinen Impfstoff gegen HIV. Erst in der vergangenen…

Elon Musk Reveals "Major Side Effects" After 2nd COVID Booster

Elon Musk Reveals "Major Side Effects" After 2nd COVID Booster …

J&J subsidiary to pay $9.75M to resolve kickback allegations

Federal prosecutors say a subsidiary of health care company Johnson & Johnson has agreed to pay nearly $10 million to…

Johnson & Johnson stock underperforms Friday when compared to competitors

Johnson & Johnson stock underperforms Friday when compared to competitors...…

U.S. fines J&J $9.75 mln over kickbacks to surgeon for overseas surgeries

...By Jonathan Stempel Jan 20 (Reuters) - Johnson & Johnson and its......…

U.S. fines J&J $9.75 million over kickbacks to surgeon for overseas surgeries

...By Jonathan Stempel (Reuters) - Johnson & Johnson and its DePuy......…

Electrosurgical Devices Global Market Report 2022: Featuring Olympus, Bovie Medical, ATMOS, Johnson and Johnson & More

DUBLIN, Jan. 20, 2023 /PRNewswire/ -- The "Electrosurgical Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key…

What 5 Analyst Ratings Have To Say About Johnson & Johnson

Latest Ratings for JNJ DateFirmActionFromTo Jan 2022Raymond JamesMaintainsOutperform Jan 2022Morgan StanleyMaintainsEqual-Weight Dec 2021Goldman SachsInitiates Coverage OnNeutral …

J&J (JNJ) to Begin Q4 Earnings Season for Pharma Sector

Growth in J&Js (JNJ) Pharma unit is expected to have been driven by drugs like Darzalex and Stelara. In the…

Johnson & Johnson stock falls Thursday, still outperforms market

Johnson & Johnson stock falls Thursday, still outperforms market...…

Johnson & Johnson: Aussichtsreicher HIV-Impfstoff schützt nicht

BERLIN (dpa-AFX) - Ein besonders aussichtsreicher Impfstoffkandidat gegen die Immunschwächekrankheit Aids schützt nicht ausreichend vor einer HIV-Infektion. Das gab der…

Johnson & Johnson: Aussichtsreicher HIV-Impfstoff schützt nicht

BERLIN (dpa-AFX) - Ein besonders aussichtsreicher Impfstoffkandidat gegen die Immunschwächekrankheit Aids schützt nicht ausreichend vor einer…

Microsoft will 10.000 Stellen streichen - United Airlines überrascht positiv - Rückschlag für Johnson & Johnson

Wien (www.aktiencheck.de) - Nachdem im Technologiesektor schon einige Unternehmen Personalkürzungen angekündigt hatten, gab gestern auch Microsoft (ISIN: US5949181045, WKN: 870747,…

Johnson & Johnson (JNJ) Stock Moves -1.51%: What You Should Know

In the latest trading session, Johnson & Johnson (JNJ) closed at $169.76, marking a -1.51% move from the previous day....…

Johnson & Johnson stock outperforms competitors despite losses on the day

Johnson & Johnson stock outperforms competitors despite losses on the day...…

J&J discontinues HIV trial in latest setback to vaccine pursuit

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

J&J’s HIV vaccine fails Phase 3 clinical trial

Johnson & Johnson’s JNJ experimental HIV vaccine is safe but not effective, and the late-stage study will be discontinued as…

Johnson & Johnson scraps HIV vaccine program after Phase 3 setback

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

UPDATE 2-J&J to discontinue trial after HIV vaccine found ineffective

... trials) Jan 18 (Reuters) - Johnson & Johnson said on Wednesday......…

J&J Ends Large HIV Vaccine Trial in Latest Setback for Field

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

J&J to discontinue HIV vaccine trial

...(Reuters) - Johnson & Johnson said on Wednesday the company......…

Annexin appoints Dr. Alain Thibault as Therapeutic Area Head of Oncology.

STOCKHOLM January 18, 2023   Annexin Pharmaceuticals AB (publ) announces that Dr. Thibault, a medical  oncologist with extensive global experience leading…

Johnson & Johnson stock falls Tuesday, underperforms market

Johnson & Johnson stock falls Tuesday, underperforms market...…

Pick Either Johnson & Johnson Stock Or Its Peer – Both May Offer Similar Returns

We believe that pharmaceutical giants Johnson & Johnson stock (NYSE: JNJ) and Merck stock (NYSE: MRK) will likely offer similar…

Johnson & Johnson stock falls Friday, underperforms market

Johnson & Johnson stock falls Friday, underperforms market...…

Gesundheitskonzern Johnson & Jonson spürt Gegenwind durch starken Dollar

NEW BRUNSWICK (dpa-AFX) - Der Gegenwind durch den starken US-Dollar hat den Gesundheitskonzern Johnson & Johnson…

US-Gesundheitskonzern Johnson & Johnson senkt wegen Dollarstärke Prognose

NEW BRUNSWICK (dpa-AFX) - Der starke Dollar bremst den Gesundheitskonzern Johnson & Johnson . Für das…